SAN JOSE, California, February 25 /PRNewswire/ --

- MICRF218 RF Solution Escapes From Jamming Source, Goes To Alternate Frequency

Micrel Inc., (Nasdaq: MCRL), an industry leader in analog, high bandwidth and Ethernet IC solutions, today announced that it is launching the world's first programmable receiver featuring jam avoidance. The MICRF218, which is part of Micrel's QwikRadio(R) family, is targeted at garage door openers and tire pressure monitoring systems. It is the world's first integrated ASK/OOK receiver with selectable IF bandwidth for 300 to 450 MHz operation. The IC is currently available in volume with pricing starting at US$1.71 for 10K quantities.

SAN JOSE, California, February 25 /PRNewswire/ --

- Fully Integrated 4A Synchronous Buck Regulator Ideal For 3V and 5V Supply Rails

PRINCETON, New Jersey, February 25 /PRNewswire/ --

The global advertising market grew to just over US$600 billion in 2007, according to The Kelsey Group, the leading provider of research, data and strategic analysis on directional and interactive local media. The firm expects global ad revenues to grow at a compound annual growth rate (CAGR) of 2.7 percent and reach US$707 billion in 2012, propelled in large part by considerable growth in the interactive segment.

HONG KONG, February 25 /PRNewswire/ --

-- Brilliant Prospects and Enhanced ROE --

The PRC's leading game developer and operator NetDragon Websoft Inc. ("NetDragon" or the "Company," with its subsidiary collectively the "Group"; Stock Code: 8288.HK) announces that it repurchased 15,975,000 shares in its capital in 16 rounds from 18 December 2007 to 19 February 2008. The price paid by the Group was approximately HK$195,000,000 in total, or between HK$11.04 and HK$14.48 per share.

ZURICH, Switzerland, February 25 /PRNewswire/ --

- Preclinical results to be presented at two international scientific meetings

ESBATech AG, a leading developer of antibody fragment therapeutics, today announced that it has achieved high concentrations of its antibody fragments in all segments of the eye with topical delivery via eye drops. These data were confirmed in several independent preclinical in vivo tests. Anticipated therapeutic concentrations of ESBATech's antibody fragments were observed in the anterior chamber (front of the eye) and in the posterior segments (back of the eye) including vitreous humour, retina, and choroid. ESBATech's lead antibody fragment ESBA105 is a TNFa antagonist that is scheduled to enter clinical development later in 2008.

NEW YORK, February 25 /PRNewswire/ --

The New York Mercantile Exchange, Inc., a subsidiary of NYMEX Holdings, Inc. (NYSE: NMX), today announced that it will introduce the first slate of futures and options contracts as part of its Green Exchange initiative on March 16 for trade date March 17. The initial contracts will be European Union Allowance (EUA) futures and options; Certified Emission Reduction (CER) futures; seasonal nitrogen oxide emission allowance contracts; annual nitrogen oxide allowance futures; and sulfur dioxide emission allowance options contracts.